MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CCCC — C4 Therapeutics, Inc.

Nasdaq

C4 Therapeutics, Inc.

CompareBack to Screener
$2.95
-0.19(-6.05%)
O
3.19
H
3.33
L
2.93
V
3.37M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

C4 Therapeutics, Inc. Statistics

Total Valuation

Market Cap$366.61M
Enterprise Value$366.61M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding123.03M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-14,588.94
EV / Salesn/a
EV / EBITDA-13,389.05
EV / EBIT-13,194.37
EV / FCF-12,216.93

Financial Position

Current Ratio9.00
Quick Ration/a
Debt / Equity0.22
Debt / EBITDA-1.90
Debt / FCF-1.73
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-10.73%
Return on Assets (ROA)-7.64%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-242
Employee Count104
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+33.48%
50-Day Moving Average$3.63
200-Day Moving Average$3.11
Relative Strength Index (RSI)30.65
Average Volume (20 Days)2,115,352

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-$27.79K
Pretax Income-$25.13K
Net Income-$25.13K
EBITDA-$27.38K
EBIT-$27.79K
Loss Per Share$-0.20

Balance Sheet

Cash & Cash Equivalents$61.27K
Total Debt$51.92K
Net Cash$9.35K
Net Cash Per Share$0.00
Equity (Book Value)$234.25K
Book Value Per Share$0.00
Working Capital$218.12K

Cash Flow

Operating Cash Flow-$26.90K
Capital Expenditures-$-64
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$30.01K
FCF Per Share$-0.00

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-0.01%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a